News for Healthier Living

Moffitt Study Finds Key Biomarker to Predict KRASG12C Inhibitor Effectiveness in Lung Cancer

A new study from Moffitt Cancer Center could help doctors predict how well patients with a specific type of lung cancer will respond to new therapies. The research, published in Clinical Cancer Research, found that measuring the interaction between two proteins, RAS and RAF, could provide valuable insights into the effectiveness of treatments for patients with KRASG12C-mutant non-small cell lung cancer, a type of lung cancer known for being particularly difficult to treat.

January 31, 2025


February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025

February 7 2025

February 6 2025

February 5 2025

February 4 2025

February 3 2025

February 2 2025

February 1 2025

January 31 2025

January 30 2025

January 29 2025